| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.3 |